Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Research Article

Preparation & Characterization of Sustained-release Floating Microsphere of Digestive Enzymes

Author(s): Bhupendra G. Prajapati*, Anand Bhagat and Biswajit Basu

Volume 20, Issue 1, 2025

Published on: 30 January, 2024

Page: [104 - 117] Pages: 14

DOI: 10.2174/0115748855274979231228103038

Price: $65

Open Access Journals Promotions 2
Abstract

Introduction: Pepsin is a proteolytic enzyme which is widely used as a digestive aid. Its dose is 300 mg - 1 gm per day in divided doses. Its biological half-life is around 3.5 hrs. Pepsin is active only in the acidic pH of the stomach; its activity decreases tremendously in the basic pH. So, it is required to retain in the stomach for maximum proteolytic activity. The goal of the current effort is to develop and assess an oral controlled floating drug delivery system for pepsin that will shorten its stay in the stomach and result in a longer effect.

Methods: The 12-hour sustained effect of pepsin floating microspheres was planned. This also improves the stability of the Pepsin by immobilizing them on the microsphere. Pepsin is widely used in chronic gastritis, so developing a floating drug delivery system is therefore necessary. In light of the aforementioned principles, a critical need for the creation of a dosage form to administer Pepsin in the stomach and boost the enzyme's effectiveness, enabling sustained action, was identified. The current study used a methodical strategy to create floating microspheres of Pepsin dosage forms.

Results: Optimization was done for floating ability, yield, entrapment efficiency, and release study using different concentrations of ethylcellulose & HPMC E4M. For parameter optimization and to demonstrate the significant impact of variables, 32 full factorial designs were used. The manufactured microspheres had good encapsulation rates, excellent floating, & excellent micromeritic properties as single-unit dosage forms.

Conclusion: It has been demonstrated that pepsin prepared as floating microspheres can be used to improve proteolytic activity and extend pepsin's gastric residence.

Keywords: Pepsin, floating microspheres, residence time, chronic gastritis, enzyme, digestive aid.

Graphical Abstract
[1]
Jain S, Agrawal G, Jain N. Floating microspheres as drug delivery system: Newer approaches. Curr Drug Deliv 2008; 5(3): 220-3.
[http://dx.doi.org/10.2174/156720108784911721] [PMID: 18673266]
[2]
Mohamed JMM, et al. Ameliorated stomach specific floating microspheres for emerging health pathologies using polymeric Konjac Glucomannan-based domperidone. Biomed Res Int 2022; 2022: 3670946.
[http://dx.doi.org/10.1155/2022/3670946]
[3]
Neelamegarajan R, et al. Formulation and evaluation of floating microspheres of Levofloxacin hemihydrate for the treatment of H. pylori infection. Journal of Pharmaceutical Chemistry 2022; 8
[4]
Lee J-H, Park TG, Choi H-K. Development of oral drug delivery system using floating microspheres. J Microencapsul 1999; 16(6): 715-29.
[http://dx.doi.org/10.1080/026520499288663] [PMID: 10575624]
[5]
Prajapati VC, Patel PR, Prajapati GB. Formulation, optimization and evaluation of sustained release microsphere of ketoprofen. J Pharm Bioallied Sci 2012; 4(5) (Suppl. 1): 101.
[http://dx.doi.org/10.4103/0975-7406.94156] [PMID: 23066178]
[6]
Piper D, Fenton BHJG. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 1965; 6(5): 506-8.
[7]
Nie L. Optimum experimental designs AC Atkinson, AN Donev and RD Tobias, with SAS Oxford. University Press, Oxford: Wiley Online Library. 2007.
[8]
Pantwalawalkar J, Nangare S. Formulation of silk fibroin-based single polymeric floating microspheres for sustained release of lafutidine. Indian Journal of Pharmaceutical Education and Research 2022; 56(2): 396-404.
[http://dx.doi.org/10.5530/ijper.56.2.59]
[9]
Ghodake J, et al. Formulation and evaluation of floating microsphere containing anti-diabetic (metformin hydrochloride) drug. Int J Pharm Tech Res 2010; 2(1): 378-84.
[10]
Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics. Drug Dev Ind Pharm 2001; 27(6): 507-15.
[http://dx.doi.org/10.1081/DDC-100105175] [PMID: 11548857]
[11]
Kale R, et al. Preparation and evaluation of floatable drug delivery system of ketorolac tromethamine. Int J Pharm Excp 2001; 32(1): 64-5.
[12]
Gadad AP, et al. Formulation and evaluation of gastroretentive floating microspheres of lafutidine 2016; 50: 76-81.
[13]
Kawashima Y, et al. Hollow microspheres for use as a floating controlled drug delivery system in the stomach 1992; 81(2): 135-40.
[http://dx.doi.org/10.1002/jps.2600810207]
[14]
Mahato RI, et al. Emerging trends in oral delivery of peptide and protein drugs 2003; 20(2.3)
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v20.i23.30]
[15]
Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Control Release 1991; 16(3): 279-89.
[http://dx.doi.org/10.1016/0168-3659(91)90004-W]
[16]
Rao MRP, Borate SG, Thanki KC, Ranpise AA, Parikh GN. Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm 2009; 35(7): 834-42.
[http://dx.doi.org/10.1080/03639040802627421] [PMID: 19337874]
[17]
Rahangdale T, et al. In vitro evaluation of floating microspheres of gabapentin by solvent evaporation method. 2022; 14(2)
[http://dx.doi.org/10.52711/0975-4377.2022.00023]
[18]
Bhise M, Shukla K, Jain S, Bhajipale N, Sudke S, Burakle P. Development and evaluation of floating microspheres of anticonvulsant drug by 3<sup>2</sup> full factorial design. Turkish Journal of Pharmaceutical Sciences 2022; 19(5): 595-602.
[http://dx.doi.org/10.4274/tjps.galenos.2021.53050] [PMID: 36317946]
[19]
Badaoui FZ, et al. Statistically optimized repaglinide-loaded floating microspheres for the gastric sustained delivery via central composite design. Technology 2022; 12(3): 1406-12.
[20]
Al Ashmawy AZ. Enhancement of hypolipidemic effect of atorvastatin calcium via floating microspheres. Zagazig J Pharm Sci 2022; 0(0): 0.
[http://dx.doi.org/10.21608/zjps.2022.124307.1026]
[21]
Prajapati BG, Patel DV. Formulation and optimization of domperidone fast dissolving tablet by wet granulation techniques using factorial design. International Journal of PharmTech Research 2010; 2: 292-9.
[22]
Bhardwaj P, et al. Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting. The Scientific World Journal 2014; 2014
[23]
Bhopte DK, Sagar R, Kori ML. Fabrication, optimization and characterization of floating microspheres of quinapril hydrochloride using factorial design method. Biomed Pharmacol J 2022; 15(4): 2011-24.
[http://dx.doi.org/10.13005/bpj/2539]
[24]
Chandrika PN, et al. Formulation and invitro evaluation of captopril floating microspheres. World J Pharma Sci 2022; 26-32.
[25]
Kumar M, Rani R, Verma R, et al. Berberine hydrochloride embedded chitosan-based novel floating microspheres: optimization, characterization, and in vivo anti-ulcer potential. Drug Deliv Lett 2022; 12(4): 287-301.
[http://dx.doi.org/10.2174/2210303112666220602123548]
[26]
Sahu R, Jain S. Development and characterization of floating microspheres of dexrabeprazole sodium for the treatment of peptic ulcer. J Drug Deliv Ther 2022; 12(5-S): 20-6.
[http://dx.doi.org/10.22270/jddt.v12i5-S.5616]
[27]
Baghel Chauhan S, Nainwani S. Formulation and evaluation of floating microspheres for an antihypertensive drug telmisartan. Res J Pharm Dos Forms Technol 2022; 14(4): 283-8.
[http://dx.doi.org/10.52711/0975-4377.2022.00046]
[28]
Karosiya SR, Vaidya VM, Bhajipale NS, Radke RS. Formulation and evaluation of gastroretentive floating microspheres loaded with lamivudine. J Drug Deliv Ther 2022; 12(4-S): 17-22.
[http://dx.doi.org/10.22270/jddt.v12i4-S.5462]
[29]
Shah R, Bhattacharya S. Preparation and physical characterization of Methotrexate encapsulated poly (n-methyl glycine) microspheres for the Rheumatoid arthritis treatment option. Results in Chemistry 2023; 100875.
[30]
Kumar K, Rai A. Development and evaluation of floating microspheres of curcumin. Trop J Pharm Res 2012; 11(5): 713-9.
[31]
Kumar S, Tiwari A, Goyal N. Floating microspheres of lafutidine: Formulation, optimization, characterization, in-vitro and in-vivo floatability studies using eudragit grades. Indian JPharma Edu Res 2022; 56(3): 681-8.
[http://dx.doi.org/10.5530/ijper.56.3.116]
[32]
Vinchurkar K, Sainy J, Khan MA. Development and optimization of floating alginate microspheres of repaglinide using Box-Behnken experimental design. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 2023; 16(1): 6281-91. [IJPSN].
[http://dx.doi.org/10.37285/ijpsn.2023.16.1.3]
[33]
Xiong YS, Li M-X, Jia R, et al. Polyethyleneimine/polydopamine-functionalized self-floating microspheres for caramel adsorption: Interactions and phenomenological mass transfer kinetics. Separ Purif Tech 2023; 313: 123315.
[http://dx.doi.org/10.1016/j.seppur.2023.123315]
[34]
Ma N, Xu L, Wang Q, et al. Development and evaluation of new sustained-release floating microspheres. Int J Pharm 2008; 358(1-2): 82-90.
[http://dx.doi.org/10.1016/j.ijpharm.2008.02.024] [PMID: 18407442]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy